BCYC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bicycle Therapeutics PLC (BCYC) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock exhibits bearish technical indicators, insider selling, and no significant positive catalysts. While the company has shown impressive revenue growth in the latest quarter, its net income remains negative, and there are no recent AI or SwingMax trading signals to suggest a strong entry point. Given the investor's impatience and preference for long-term stability, holding off on this stock is advisable until clearer positive signals emerge.
The technical indicators are bearish. The MACD is negatively expanding, RSI is neutral at 27.602, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 5.1 and resistance at 5.684. The stock has a 60% chance to decline slightly (-0.27%) in the next day and -1.93% in the next week.
Revenue increased significantly (338.49% YoY) in the latest quarter, and gross margin remains strong at 100%.
Insiders are selling heavily, with a 253.11% increase in selling activity over the last month. No recent news or congress trading data. No AI Stock Picker or SwingMax signals. The stock has a bearish trend and is expected to decline slightly in the short term.
In Q3 2025, revenue increased to $11.73M (up 338.49% YoY). Net income improved but remains negative at -$59.1M (up 16.33% YoY). EPS improved to -0.85 (up 14.86% YoY). Gross margin remains at 100%.
No recent analyst ratings or price target changes available.
